| |
| |
|
| Insider
Information: |
Vagelos P Roy |
| Relationship: |
Director |
| City: |
Tarrytown |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
717,380 |
|
|
Indirect Shares
|
1,322,453 |
|
|
| Direct
Value |
$312,768,276 |
|
|
|
Indirect Value
|
$169,901,771 |
|
|
| Total
Shares |
2,039,833 |
|
|
| Total
Value |
$482,670,048 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Regeneron Pharmaceuticals Inc |
REGN |
Director |
2023-04-03 |
312,578 |
2023-04-03 |
154,526 |
Premium* |
|
|
Innoviva Inc |
INVA |
Director |
2009-12-23 |
404,802 |
2009-12-23 |
1,167,927 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
266 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 11 of 11
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| REGN |
Regeneron Pharmaceuticals... |
Chairman of the Board |
• • – |
2016-11-07 |
4 |
OE |
$20.32 |
$1,562,506 |
D/D |
76,895 |
515,726 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2004-09-28 |
4 |
GD |
$0.00 |
$0 |
I/I |
24,393 |
527,322 |
|
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2009-12-08 |
4 |
OE |
$8.77 |
$1,644,375 |
D/D |
187,500 |
548,751 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2004-06-25 |
4 |
GD |
$0.00 |
$0 |
I/I |
20,870 |
551,715 |
|
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Chairman of the Board |
• • – |
2014-08-26 |
4 |
OE |
$11.64 |
$3,537,501 |
D/D |
303,909 |
552,449 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Chairman of the Board |
• • – |
2018-06-20 |
4 |
OE |
$16.80 |
$2,575,003 |
D/D |
153,274 |
553,121 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Chairman of the Board |
• • – |
2018-07-09 |
4 |
OE |
$16.80 |
$2,575,003 |
D/D |
153,274 |
553,121 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2010-06-18 |
4 |
A |
$0.00 |
$0 |
D/D |
31,761 |
560,512 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Chairman of the Board |
• • – |
2016-05-12 |
4 |
OE |
$20.32 |
$4,687,499 |
D/D |
230,684 |
563,564 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2004-03-29 |
4 |
GD |
$0.00 |
$0 |
I/I |
15,900 |
572,585 |
|
- |
|
| INVA |
Innoviva Inc |
Director |
– • – |
2004-10-04 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
587,092 |
|
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2003-12-31 |
5 |
GD |
$15.10 |
$223,269 |
I/I |
14,786 |
588,485 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2003-09-25 |
4 |
GD |
$18.96 |
$208,674 |
I/I |
11,006 |
603,271 |
|
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2003-06-26 |
4 |
GD |
$15.89 |
$210,336 |
I/I |
13,237 |
614,277 |
|
- |
|
| INVA |
Innoviva Inc |
Director |
– • – |
2008-04-22 |
4 |
A |
$0.00 |
$0 |
D/D |
28,898 |
673,968 |
0 |
- |
|
| INVA |
Innoviva Inc |
Director |
– • – |
2004-10-04 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,003,325 |
|
- |
|
266 Records found
|
|
Page 11 of 11 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
